Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/27/26 18:35 | 2/25/26 | PFE | Health | Drug | Pharmaceutical Preparations | Sahni Payal | NY | O | EVP | 1 | M.d | 1,924 | 33.82 | 0 | 57 | 42 | D | |||||||||||||||
2/27/26 18:35 | 2/25/26 | PFE | Health | Drug | Pharmaceutical Preparations | Lankler Douglas M | NY | O | EVP | 1 | M.d | 4,157 | 33.82 | 0 | 123 | 290 | 165 | D | ||||||||||||||
2/27/26 18:35 | 2/25/26 | PFE | Health | Drug | Pharmaceutical Preparations | Damico Jennifer B. | NY | O | SVP,Cont | 1 | M.d | 594 | 33.82 | 0 | 18 | 13 | D | |||||||||||||||
2/27/26 18:34 | 2/25/26 | PFE | Health | Drug | Pharmaceutical Preparations | Bourla Albert | NY | DO | CB,CEO | 1 | M.d | 16,627 | 33.82 | 0 | 492 | 395 | D | |||||||||||||||
2/27/26 18:34 | 2/25/26 | PFE | Health | Drug | Pharmaceutical Preparations | Fonseca Lidia | NY | O | EVP | 1 | M.d | 1,924 | 33.82 | 0 | 57 | 46 | D | |||||||||||||||
2/27/26 18:34 | 2/25/26 | PFE | Health | Drug | Pharmaceutical Preparations | McDermott Michael | NY | O | EVP | 1 | M.d | 1,283 | 33.82 | 0 | 38 | 104 | 74 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |